Syneron Medical Ltd.
Syneron Medical Ltd., a prominent player in the aesthetic medical device industry, is headquartered in Israel (IL) and operates globally, with a strong presence in North America, Europe, and Asia. Founded in 2000, the company has established itself as a leader in innovative technologies for non-invasive and minimally invasive aesthetic treatments. Syneron Medical is renowned for its advanced laser and light-based systems, including the popular Candela brand, which offers a range of solutions for hair removal, skin rejuvenation, and body contouring. Their unique combination of proprietary technologies sets them apart in a competitive market, ensuring effective and safe treatments for patients. With a commitment to research and development, Syneron Medical has achieved significant milestones, solidifying its market position and earning recognition for excellence in aesthetic medicine.
DitchCarbon Score
How does Syneron Medical Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Syneron Medical Ltd.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Syneron Medical Ltd.'s reported carbon emissions
Syneron Medical Ltd., headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Syneron Medical Ltd. may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the company operates within the medical technology sector, it is essential for them to consider the growing emphasis on sustainability and climate responsibility in the industry. Without clear emissions data or reduction strategies, Syneron Medical Ltd. may face challenges in aligning with global climate goals and meeting stakeholder expectations regarding environmental performance.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Syneron Medical Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
